ZA933469B - Fatty acid treatment - Google Patents

Fatty acid treatment

Info

Publication number
ZA933469B
ZA933469B ZA933469A ZA933469A ZA933469B ZA 933469 B ZA933469 B ZA 933469B ZA 933469 A ZA933469 A ZA 933469A ZA 933469 A ZA933469 A ZA 933469A ZA 933469 B ZA933469 B ZA 933469B
Authority
ZA
South Africa
Prior art keywords
fatty acid
acid treatment
dgla
gla
gamma
Prior art date
Application number
ZA933469A
Other languages
English (en)
Inventor
David Frederick Horrobin
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA933469B publication Critical patent/ZA933469B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
ZA933469A 1992-05-27 1993-05-18 Fatty acid treatment ZA933469B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211229A GB9211229D0 (en) 1992-05-27 1992-05-27 Fatty acid treatment

Publications (1)

Publication Number Publication Date
ZA933469B true ZA933469B (en) 1994-09-26

Family

ID=10716100

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933469A ZA933469B (en) 1992-05-27 1993-05-18 Fatty acid treatment

Country Status (15)

Country Link
US (1) US5380757A (xx)
EP (1) EP0572159B1 (xx)
JP (1) JPH0640903A (xx)
AT (1) ATE156015T1 (xx)
AU (1) AU660223B2 (xx)
CA (1) CA2096556A1 (xx)
DE (1) DE69312579T2 (xx)
DK (1) DK0572159T3 (xx)
ES (1) ES2107622T3 (xx)
GB (1) GB9211229D0 (xx)
GR (1) GR3025178T3 (xx)
NO (1) NO931923L (xx)
NZ (1) NZ247660A (xx)
TW (1) TW336171B (xx)
ZA (1) ZA933469B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
US6762202B2 (en) 2000-05-09 2004-07-13 Nitromed, Inc. Infrared thermography and methods of use
CA2417552C (en) 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US20030236284A1 (en) * 2002-06-14 2003-12-25 Alcon, Inc. Use of hydroxyeicosatetraenoic acid compounds to treat vaginal dryness
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
WO2006089348A1 (en) * 2005-01-20 2006-08-31 Kayban Pty Ltd Anti-microbial agent
EP2211881A4 (en) * 2007-11-01 2012-01-04 Wake Forest University School Of Medicine COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING DISEASES AFFECTING MAMMALS
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US20110159074A1 (en) * 2009-12-30 2011-06-30 Raphael Warren Wipe Article Comprising Lotion Composition Comprising Omega-6 Fatty Acid And Method Of Improving Skin Barrier Function
JP2013515778A (ja) * 2009-12-30 2013-05-09 ザ プロクター アンド ギャンブル カンパニー ω−６脂肪酸を含むローション組成物を含む拭き取り用物品
US20120083747A1 (en) * 2010-10-01 2012-04-05 Leo Galland Vaginal renewal complex and applicator
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
BR112016028518A2 (pt) 2014-06-04 2017-08-22 Dignity Sciences Ltd composições farmacêuticas que compreendem dgla e uso do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB9116054D0 (en) * 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments

Also Published As

Publication number Publication date
DK0572159T3 (da) 1998-03-09
TW336171B (en) 1998-07-11
GB9211229D0 (en) 1992-07-08
NZ247660A (en) 1997-06-24
ES2107622T3 (es) 1997-12-01
DE69312579T2 (de) 1998-03-05
NO931923L (no) 1993-11-29
AU3861193A (en) 1993-12-02
JPH0640903A (ja) 1994-02-15
GR3025178T3 (en) 1998-02-27
EP0572159A1 (en) 1993-12-01
ATE156015T1 (de) 1997-08-15
US5380757A (en) 1995-01-10
CA2096556A1 (en) 1993-11-28
DE69312579D1 (de) 1997-09-04
EP0572159B1 (en) 1997-07-30
AU660223B2 (en) 1995-06-15
NO931923D0 (no) 1993-05-26

Similar Documents

Publication Publication Date Title
GB9211229D0 (en) Fatty acid treatment
HK37694A (en) Fatty acids compositions
GR3006403T3 (xx)
NO940035L (xx)
IE842424L (en) Topical preparations containing tar and fatty acids
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
TW223589B (xx)
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
GB9412925D0 (en) Combination of aldose reductase inhibitors with gamma-linolenic (GLA) dihomogammalinolenic (DGLA) or arachidonic (AA) acids in the treatment of diabetic